Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Canada / NCT07439627
Starting soon Not applicable

Evaluating Novel Approaches That Engage and Support Vulnerable Patient Groups to Equitably Access Primary Care

NCT07439627 · tracked via the Priya Life Science Canada tracker
Sponsor
Unity Health Toronto
Phase
Not applicable
Started
2026-03
Last updated
2026-03-03

Condition(s) studied

Access to Primary Care

Investigational drug(s) / intervention(s)

Primary care connector

Primary care connector: A primary care connector will give participants the name of a primary care provider in their area who is accepting new patients based on a list containing this information generated prior to the start of the trial.

Study summary

The goal of this initial clinical trial is to gather information for building a future national trial in Canada that can continuously look at different ways of helping people made vulnerable get a primary care provider. The trial will take place in the Toronto region and will help researchers decide how to plan the future trial.

The main question that this trial is aiming to answer is:

• For those made vulnerable who do not currently have a primary care provider, will assistance from a Primary Care Connector trained specifically with knowledge of the local health system, help to better connect those people to primary care providers compared to written information alone?

Researchers will compare giving participants the name of a provider that is accepting new patients in their area, to only giving participants existing information on how to find a provider, to see if giving the name of a provider accepting new patients works better to help people get connected to a provider.

Participants will:

* Get the name of a primary care provider in their area who is accepting new patients or get existing information on how to find a primary care provider.
* Call the provider to try and get an appointment or use the information given to find a provider.
* Tell the study team if they have found a provider.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Unattached adults (18+) made vulnerable who are seeking a primary care provider within the boundaries created by the Toronto Region Primary Care Workforce Planning Toolkit. Exclusion Criteria: * Patients under 18 years old. * Patients above 18 years who have not been made vulnerable and are already registered and/or attached to a primary care organization within the boundaries created by the Toronto Region Primary Care Workforce Planning Toolkit.

Primary outcome measure(s)

  • Patient enrollment — From contact with a primary care connector to 3-4 weeks later.
    The number of patients made vulnerable enrolled in the primary care organizations across the participating sub-regions of the study is the primary outcome measure.

Trial sites (1)

FacilityCityRegionStatus
Unity Health Toronto Toronto Ontario

More Unity Health Toronto trials in Canada

Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial Recruiting
Muscle Recruitment During Neck Flexion and Inspiratory Muscle Training Recruiting
PREdicting Failure of Non-inVasIve Ventilatory Support Using Non-invaSIve mONitoring in Non-intubated Patients With Acute Hypoxemic Respiratory Failure or Post-extubation Failure. The PREVISION Study Recruiting
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery Recruiting
Digital-Supported Versus Standard Consent for Advanced Therapeutic Endoscopy Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07439627 on ClinicalTrials.gov ↗ ← All trials in Canada